Live Markets
Saturday, September 12, 2026·George Town, KY·29°·Partly Cloudy
Markets Open · NYSE·Newsletter·Masthead·
VOL. XII · NO. 117Established MMXIV · George Town, Grand CaymanAtlantic Edition · $4.50

The Cayman Journal

Finance · Business · Technology · Caribbean & Global Affairs
Markets · Healthcare

Neogen Corporation (NEOG)

NMS · Medical Devices

$11.78+0.01 (+0.08%)Quote refreshed

Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires

Market Cap
$2.57B
P/E (TTM)
EPS
$-0.04
Div Yield
52W Range
$4.90–$12.85
Beta
1.76

Company overview

Next earnings: 2026-10-08(26d)

Neogen Corporation develops, manufactures, and markets various products and services for food and animal safety in the United States and internationally. It operates through Food Safety and Animal Safety segments. The company offers diagnostic test kits and complementary products to detect dangerous and/or unintended substances in human food and animal feed, such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, ruminant by-products, meat speciation, drug residues, pesticide residues, and general sanitation concerns for food producers and processors. It also provides reagents and test kits used in immunoassay production, forensic and animal toxicology, and life science research; unique colorimetric and chemiluminescent substrates for research use; veterinary instruments and delivery systems used for administering antibiotics and vaccines under the Ideal and Prima Tech brands; and precision instruments designed for injections, topical and oral administration, artificial insemination, and animal identification for farmers, ranchers, and veterinarian under the Prima Tech brand. In addition, the company offers digestive aids and nutritional supplements; Natural Vitamin E-AD to address vitamin deficiencies in swine, cattle, and sheep; RenaKare; companion animal parasiticides under Provecta brand; BotVax B; EqStim; ImmunoRegulin, used in dogs to assist in managing pyoderma; companion animal parasiticides under the Provecta brand; rodent and insect control products under the Ramik, CyKill, Havoc, Prozap, SureKill, and StandGuard brands. Further, it markets Uniprim, a veterinary antibiotic; operates sgenomics labs offering DNA genotyping, sequencing, and trait analysis for livestock and companion animals; and provides software systems that help testers to analyze and store results and perform analysis on the results from multiple locations over extended periods. Neogen Corporation was incorporated in 1981 and is headquartered in Lansing, Michigan.

Peers in Medical Devices

All in industry →

Recent press releases

April 2026

5 months ago8-KHealthcare

NEOGEN CORP — 8-K Filing

NEOGNEOGEN CORP

# 🧾 What This Document Is This is a **quarterly earnings report** (Form 8-K with an exhibit) for Neogen Corporation. It's like a "report card" for the company's third fiscal quarter, which ended on February 28, 2026. Companies are required to file these with the SEC to update investors on their fin

Read summaryView on SEC EDGAR

SEC filings

All filings →
1 recent filing shown in the timeline above. View all SEC filings →

Neogen Corporation has no reported insider trades in the last 90 days.

Institutional holders

All holders →
As of 2025-12-31 · prior 2025-09-30
144,502 sh-99.2%
6,864,470 sh● NEW
32,509,026 sh+1.5%
23,801,905 sh-0.7%
14,126 sh-99.6%
8,777,500 sh-37.6%
6,500,000 sh+30.0%

People at Neogen Corporation

All people →

Quarterly financials

Full financials →
Revenue trend
11/24
$83.3M
NI
02/25
$23.8M
NI
08/25
$209.2M
NI
RevenueNI = Net Income
EPS trend (diluted)
Latest: $0.17
Prior: $-0.05
Revenue sparkline
Neogen Corporation (NEOG) Stock Quote, Press... | Cayman Journal | Cayman Journal